Sign in

Lost your password?
(close)

Brexit

Brexit Bites: EMA cuts off Britain

The European Medicines Agency has cut Britain out of its contracts 7 months ahead of Brexit. “You might have been working on a cancer drug for decades and built up…

UK Life Sciences Firms Struggle in Post-Brexit War for EU Talent

UK pharmaceutical and biotech companies are already finding it increasingly difficult to attract talent from…

Brexit: A Window of Opportunity for France’s Drug Regulator?

As the UK prepares to leave the European Union in March 2019, stakeholders across the European life sciences…

Roche boss: Brexit will make the UK less competitive

Last week, Roche Boss Severin Schwan expressed concern that Brexit could further slow the UK drug approval process.…

Latest Report

In Conversation

Chris Fox – General Manager, Amgen UK & Ireland

Christine (Chris) Fox, VP and general manager UK and Ireland at Amgen, two months into her first country manager position and first time in a role outside of North America, discusses the creation of new, innovative partnership models with stakeholders across the healthcare spectrum, how Amgen is leveraging its biologic manufacturing expertise to move into biosimilars, and the importance of…

Interview: Erik Nordkamp – Managing Director, Pfizer…

Interview: Liam O’Toole – CEO, Arthritis Research UK

Brexit Facts & Figures Snapshot

There is much debate surrounding the potential impact on the UK’s life sciences industry of the…

Related Report

Philippe Lamoureux – Director, LEEM, France

Philippe Lamoureux, director of LEEM, the pharmaceutical industry’s association in France, reflects on the winds…

Brexit and Irish Pharma

The UK’s decision to leave the EU in Summer 2016 sent shockwaves throughout Europe and left neighbouring…

Brexit: Much ado about nothing?

Brexit, Brexit, Brexit. It’s all anyone can talk about and yet nobody can tell you with certainty what to expect.…

NHS England’s Long-Term Plan to be Funded by £20.5 Billion

Today NHS England have released their long-term plan to ensure the future of the NHS and the continued care of UK…

Pfizer’s Nordkamp Takes ABPI Presidency

Erik Nordkamp, managing director of Pfizer UK, has been confirmed as the new president of the Association of the…

EMA Headquarters to Move to Amsterdam

The European Medicines Agency (EMA), the EU body responsible for the evaluation of medicinal products for use…

The European Medicines Verification System Launches to Tackle Fake Drugs

The 9th February 2019 marked the launch of the European Medicines Verification System (EMVS) which will use…

We use cookies to ensure that we give you the best experience on our site. For more info click here